ArticleAntioxidants (Basel, Switzerland)2026
HGA-Induced Oxidative Stress Impairs Autophagy via Lysosomal Dysfunction in Alkaptonuria.
Article in Antioxidants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Alkaptonuria (AKU) is a rare metabolic disorder caused by homogentisate 1,2-dioxygenase deficiency, leading to systemic accumulation of homogentisic acid (HGA) and progressive tissue degeneration characterized by dark urine, ochronosis, and severe osteoarthropathy. Chronic exposure to HGA promotes oxidative stress, chondroptosis, secondary amyloidosis, and impaired autophagy, an essential process for maintaining chondrocyte homeostasis. This study investigated the mechanisms potentially involved in autophagy dysregulation in AKU using the human C20/A4 chondrocyte line treated with 0.1 mM HGA, an established in vitro model of the disease. The findings were then verified using chondrocyte cells and cartilage tissue obtained from AKU biopsies. HGA treatment induced a time-dependent increase in oxidative stress, evidenced by elevated ROS levels, 4-HNE accumulation, and overproduction of mitochondrial superoxide. Autophagy assessment showed an early increase in autophagy-related markers, with increased LC3 and p62 expression and enhanced lysosomal biogenesis (LAMP1). However, prolonged HGA exposure was associated with reduced LC3/LAMP1 colocalization, persistent p62 accumulation, altered acidic compartment staining, and accumulation of autophagy-related structures, supporting a dysregulation of the autophagy-lysosomal pathway. Live-cell imaging further supported a transition from functional autophagy to lysosomal failure under chronic oxidative stress. Overall, this study suggests that prolonged HGA exposure disrupts the interplay between oxidative stress and autophagic flux. The progressive collapse of these adaptive mechanisms may contribute to chondrocyte degeneration and to the pathogenesis of cartilage damage in AKU.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.